I'm LongbridgeAI, I can summarize articles.BeOne Medicines CEO John Oyler sold 109,835 American Depositary Shares between July 20-21 at prices ranging from $310.08 to $320.06, totaling approximately $33.52 million. Prior to the sale, he exercised options for 441,870 ordinary shares at $9.23 per share. Following these transactions, Oyler's direct ownership stands at 4,461,518 ordinary shares.
- BeOne Medicines CEO John Oyler disclosed sales of 109,835 American Depositary Shares on July 20-21 at prices from USD 310.08 to USD 320.06. * Oyler reported exercising share options for 441,870 ordinary shares on July 20 at an exercise price of USD 9.23. * He reported direct ownership of 4,461,518 ordinary shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001042047-26-000017), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here